Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: location (194), surroundings (17), scenery (3), situation (241), background (198), set (912)

Melatonin sleep electroencephalogram (EEG) - patient information

Description: Information to help parents prepare for their child's EEG with melatonin
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Melatonin-sleep-electroencephalogram-EEG-2213-PIL.pdf

Gallows traction - patient information

Description: Gallows traction Information for patients, parents and guardians We’ve given you this factsheet because your child is due to have
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Gallows-traction-2163-PIL.pdf

Children's cystic fibrosis social work - patient information

Description: Southampton Children's Hospital can offer the support of a social worker to support children and young people who use the children's
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Childrens-cystic-fibrosis-social-work-1216-PIL.PDF

Children's allergy clinic - patient information

Description: We have given you this factsheet to give you more information about our allergy clinic and the service we provide at
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Childrens-allergy-clinic-2431-PIL.pdf

Permission to refuse blood

Description: Mr Wheeler highlights a case of a 17 year old refusing a blood transfusion.
Url: /HealthProfessionals/Clinical-law-updates/Permission-to-refuse-blood.aspx

VR-RituximabVenetoclaxCycle_1_VenetoclaxDoseTitration

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia VR-RITUXIMAB-VENETOCLAX (high risk) Cycle 1 – Venetoclax dose titration Regimen • CLL – VR Rituximab Venetoclax (high
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/VR-RituximabVenetoclaxCycle-1-VenetoclaxDoseTitration.pdf

Ibrutinib

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia Regimen Ibrutinib • CLL – Ibrutinib Indication • NICE TA 429 recommends ibrutinib alone within its marketing authorisation as
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Ibrutinib.pdf

Chlorambucil_7day

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia Chlorambucil (7 day) There are several versions of this protocol each using a different dose or
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Chlorambucil-7day.pdf

Chlorambucil_14day

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia Chlorambucil (14 day) There are several versions of this protocol each using a different dose or
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Chlorambucil-14day.pdf

AmsacrineCytarabineEtoposide_MACE

Description: Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA AMSACRINE-CYTARABINE-ETOPOSIDE In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Amsacrine-Cytarabine-Etoposide (MACE) Indication
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/AmsacrineCytarabineEtoposide-MACE.pdf

621 to 630 of 948

Previous … 61 62 63 64 65 … Next